ScoreWhy is Japan Tissue Engineering Co., Ltd. ?
1
Poor Management Efficiency with a low ROE of 0.47%
- The company has been able to generate a Return on Equity (avg) of 0.47% signifying low profitability per unit of shareholders funds
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -357.39
- Poor long term growth as Net Sales has grown by an annual rate of 0.64% and Operating profit at -19.88% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -357.39
- The company has been able to generate a Return on Equity (avg) of 0.47% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 0.64% and Operating profit at -19.88% over the last 5 years
4
The company has declared positive results in Jun'2026 after 4 consecutive negative quarters
- RAW MATERIAL COST(Y) Fallen by -32.3% (YoY)
- NET SALES(Q) Highest at JPY 766.85 MM
- OPERATING PROFIT(Q) Highest at JPY 92.77 MM
5
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 52.13%, its profits have fallen by -201%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Japan Tissue Engineering Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Japan Tissue Engineering Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Japan Tissue Engineering Co., Ltd.
52.13%
0.22
57.99%
Japan Nikkei 225
59.79%
2.03
29.50%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.64%
EBIT Growth (5y)
-19.88%
EBIT to Interest (avg)
-373.94
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.42
Tax Ratio
0.54%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.59%
ROE (avg)
0.47%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.55
EV to EBIT
-43.90
EV to EBITDA
-66.10
EV to Capital Employed
10.67
EV to Sales
9.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-24.30%
ROE (Latest)
-8.76%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend23What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -32.3% (YoY
NET SALES(Q)
Highest at JPY 766.85 MM
OPERATING PROFIT(Q)
Highest at JPY 92.77 MM
OPERATING PROFIT MARGIN(Q)
Highest at 12.1 %
PRE-TAX PROFIT(Q)
Highest at JPY 63.05 MM
NET PROFIT(Q)
Highest at JPY 52.24 MM
EPS(Q)
Highest at JPY 1.29
-1What is not working for the Company
CASH AND EQV(HY)
Lowest at JPY 6,597.73 MM
Here's what is working for Japan Tissue Engineering Co., Ltd.
Net Sales
At JPY 766.85 MM has Grown at 40.53%
over average net sales of the previous four periods of JPY 545.69 MMMOJO Watch
Near term sales trend is very positive
Net Sales (JPY MM)
Pre-Tax Profit
At JPY 63.05 MM has Grown at 143.42%
over average net sales of the previous four periods of JPY -145.19 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (JPY MM)
Net Profit
At JPY 52.24 MM has Grown at 135.73%
over average net sales of the previous four periods of JPY -146.19 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (JPY MM)
Net Sales
Highest at JPY 766.85 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Operating Profit
Highest at JPY 92.77 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (JPY MM)
Operating Profit Margin
Highest at 12.1 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at JPY 63.05 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (JPY MM)
Net Profit
Highest at JPY 52.24 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
EPS
Highest at JPY 1.29
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (JPY)
Raw Material Cost
Fallen by -32.3% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Japan Tissue Engineering Co., Ltd.
Cash and Eqv
Lowest at JPY 6,597.73 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
